Enhancement of Platelet Recovery After Myelosuppressive Chemotherapy by Recombinant Human Megakaryocyte Growth and Development Factor in Patients With Advanced Cancer
- 15 August 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (15) , 2852-2861
- https://doi.org/10.1200/jco.2000.18.15.2852
Abstract
PURPOSE: To explore the influence of dose and schedule on the ability of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) to abrogate thrombocytopenia after mul...Keywords
This publication has 38 references indexed in Scilit:
- Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG‐rHuMGDFBritish Journal of Haematology, 1997
- Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung CancerNew England Journal of Medicine, 1997
- Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancerPublished by Elsevier ,1996
- The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production.Proceedings of the National Academy of Sciences, 1994
- Molecular cloning and chromosomal localization of the human thrombopoietin geneFEBS Letters, 1994
- Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpICell, 1994
- Thrombopoietin — at lastNature, 1994
- Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivoNature, 1994
- Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligandNature, 1994
- EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPYThe Lancet, 1988